Add to collection
  • + Create new collection
    • Bottle of DIABECELL® type 1 diabetes medication.
    Rights: Living Cell Technologies Ltd Published 2 November 2011 Size: 52 KB Referencing Hub media

    The Living Cell Technologies (LCT) DIABECELL product consists of encapsulated insulin-producing pig cells that are used to treat people with type 1 diabetes.

      Appears in

      ARTICLE

      Preventing pig cell transplant rejection

      Living Cell Technologies (LCT) encapsulates pancreatic pig cells inside a special coating before transplanting them into type 1 diabetics. This prevents them from being rejected by the patient’s ...

      READ MORE
      MORE
      Add to favourites
      Add to collection
    1. + Create new collection
      2. ARTICLE

      Trialling pig cell transplants

      Clinical trials of Living Cell Technologies (LCT) pig cell transplants began in 2009. The trials show that encapsulated pig cells are safe and improve blood sugar control in type 1 diabetics ...

      READ MORE
      MORE
      Add to favourites
      Add to collection
    2. + Create new collection
      3. ARTICLE

      Pig cell transplants – introduction

      Living Cell Technologies (LCT) is a New Zealand company at the forefront of xenotransplantation research. Use our resources to explore why and how they’re using pig cells to treat disease ...

      READ MORE
      MORE
      Add to favourites
      Add to collection
    3. + Create new collection
        4. Go to full glossary
        Download all
        Email Us

        See our newsletters here.